PodParley PodParley
PodParley
Cambridge, UK based Alchemab Therapeutics last week signed a second collaboration with Eli Lilly worth up to $415M to license its IND ready program for ALS and other neurodegenerative diseases episode artwork

EPISODE · May 15, 2025 · 11 MIN

Cambridge, UK based Alchemab Therapeutics last week signed a second collaboration with Eli Lilly worth up to $415M to license its IND ready program for ALS and other neurodegenerative diseases

from BiotechTV - News · host BiotechTV

CEO Jane Osbourn describes Alchemab's platform, which looks for people who are resilient to disease and then sequences them to understand why, and discusses this week's deal and the company's prior one with Lilly as well.

What this episode covers

CEO Jane Osbourn describes Alchemab's platform, which looks for people who are resilient to disease and then sequences them to understand why, and discusses this week's deal and the company's prior one with Lilly as well.

NOW PLAYING

Cambridge, UK based Alchemab Therapeutics last week signed a second collaboration with Eli Lilly worth up to $415M to license its IND ready program for ALS and other neurodegenerative diseases

0:00 11:31

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

Beating loneliness by bridging the generation gap

Apr 21, 2026 ·13m

Robotics and the Future of Aged Care

Apr 19, 2026 ·16m

The Purpose Paradox: Why Baby Boomers Delay Retirement

Apr 17, 2026 ·13m

A Growing Movement Aims to Prepare All Physicians to Care for Older Adults

Apr 15, 2026 ·12m

Defeating Recurring Charges on Cancelled Credit Cards

Apr 13, 2026 ·11m

If Your Dad Has These 11 Odd Habits, He's More Lonely Than He Admits

Apr 11, 2026 ·16m

Similar Podcasts

Breaking News Show | eTurboNews Juergen Thomas Steinmetz News is relevant to the global travel and tourism industry, human rights and global issues.Breaking news when it happens and only from the source. Show Nuff Entertainment News We write about Entertainment News from around the world. celebrities, sports, movies, and more... All On A Positive Level!!! Tips, News and Stories for Older Adults Esther C Kane CAPS, C.D.S. "Tips, News, and Stories for Older Adults" delivers weekly insights tailored for seniors. We bring you summaries of curated news, practical advice, and inspiring stories that matter to the 55+ community. From health and finance to technology and lifestyle, our content keeps you informed and engaged. Sourced from trusted outlets, each episode offers valuable information for navigating your golden years. Join us as we explore aging with positivity, wisdom, and engaging stories. Your perfect companion for staying active, learning, and embracing life's later chapters. AI Erik's Podcast Audio Erik Conn The AI News Podcast where we talk AI.

Frequently Asked Questions

How long is this episode of BiotechTV - News?

This episode is 11 minutes long.

When was this BiotechTV - News episode published?

This episode was published on May 15, 2025.

What is this episode about?

CEO Jane Osbourn describes Alchemab's platform, which looks for people who are resilient to disease and then sequences them to understand why, and discusses this week's deal and the company's prior one with Lilly as well.

Can I download this BiotechTV - News episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!